SCHEMBL6960719

SCHEMBL6960719

O=c1oc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(O)c1SCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.39
DAO P14920 5/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
PTPN1 P18031 2/20 0.38
PTPN2 P17706 1/20 0.38
PTPN6 P29350 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
RXRG P48443 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965413 0.91 DAO (0.44) DAOCNR2PTPN1PTPN2PTPN6
SCHEMBL6954786 0.85 SMN1; SMN2 (0.50) ARDAOPTPN1CCNCCDK8
SCHEMBL6963460 0.82 EGFR (0.41) DAOPTPN1POLBSMN1; SMN2L3MBTL1
SCHEMBL6954509 0.82 NPC1 (0.47) ARDAOPTPN1POLBSMN1; SMN2
SCHEMBL6964669 0.81 ELANE (0.39) DAOCNR2PTPN1POLBSMN1; SMN2
SCHEMBL6959378 0.81 PTPN1 (0.41) DAOCNR2PTPN1PTPN2PTPN6
SCHEMBL6965958 0.80 ELANE (0.40) PTPN1POLBSMN1; SMN2L3MBTL1PKM
SCHEMBL6963367 0.80 POLB (0.45) ARDAOPTPN1CCNCCDK8
SCHEMBL6960796 0.80 TNKS (0.47) DAOPOLBSMN1; SMN2L3MBTL1CYP1A1
SCHEMBL8437014 0.80 AR (0.48) ARCNR1CNR2PTPN1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed